116 related articles for article (PubMed ID: 22141295)
1. Temozolomide induced liver injury.
Dixit S; Hingorani M; Afzal P; Campbell AP
Acta Neurol Belg; 2011 Sep; 111(3):249-51. PubMed ID: 22141295
[TBL] [Abstract][Full Text] [Related]
2. Valproic acid related idiosyncratic drug induced hepatotoxicity in a glioblastoma patient treated with temozolomide.
Neyns B; Hoorens A; Stupp R
Acta Neurol Belg; 2008 Dec; 108(4):131-4. PubMed ID: 19239041
[TBL] [Abstract][Full Text] [Related]
3. Encouraging experience of concomitant Temozolomide with radiotherapy followed by adjuvant Temozolomide in newly diagnosed glioblastoma multiforme: single institution experience.
Jalali R; Basu A; Gupta T; Munshi A; Menon H; Sarin R; Goel A
Br J Neurosurg; 2007 Dec; 21(6):583-7. PubMed ID: 18071985
[TBL] [Abstract][Full Text] [Related]
4. Acute temozolomide induced liver injury : Mixed type hepatocellular and cholestatic toxicity.
Aygun C; Altınok AY; Çakır A; Agan AF; Balaban Y
Acta Gastroenterol Belg; 2016; 79(4):487-489. PubMed ID: 28209108
[TBL] [Abstract][Full Text] [Related]
5. Temozolomide in radio-chemotherapy combined treatment for newly-diagnosed glioblastoma multiforme: phase II clinical trial.
Lanzetta G; Campanella C; Rozzi A; Nappa M; Costa A; Fedele F; Innocenzi G; Gagliardi FM; Salvati M; Minniti G; Frati A; Frati L; Vecchione A
Anticancer Res; 2003; 23(6D):5159-64. PubMed ID: 14981983
[TBL] [Abstract][Full Text] [Related]
6. Acute temozolomide induced liver injury: mixed type hepatocellular and cholestatic toxicity.
Aygun C; Altınok AY; Çakır A; Agan AF; Balaban Y
Acta Gastroenterol Belg; 2016; 79(2):363-365. PubMed ID: 27821033
[TBL] [Abstract][Full Text] [Related]
7. Risk of severe acute liver injury among patients with brain cancer treated with temozolomide: a nested case-control study using the healthcore integrated research database.
Desai VCA; Quinlan SC; Deitz AC; He J; Holick CN; Lanes S
J Neurooncol; 2017 Aug; 134(1):89-95. PubMed ID: 28717885
[TBL] [Abstract][Full Text] [Related]
8. Acute liver injury induced by levetiracetam and temozolomide co-treatment.
Khoury T; Chen S; Abu Rmeileh A; Daher S; Yaari S; Benson AA; Cohen J; Mizrahi M
Dig Liver Dis; 2017 Mar; 49(3):297-300. PubMed ID: 28034663
[TBL] [Abstract][Full Text] [Related]
9. Severe cholestatic hepatitis due to temozolomide: an adverse drug effect to keep in mind. Case report and review of literature.
Grieco A; Tafuri MA; Biolato M; Diletto B; Di Napoli N; Balducci N; Vecchio FM; Miele L
Medicine (Baltimore); 2015 Mar; 94(12):e476. PubMed ID: 25816026
[TBL] [Abstract][Full Text] [Related]
10. Chemoradiotherapy of newly diagnosed glioblastoma with intensified temozolomide.
Weiler M; Hartmann C; Wiewrodt D; Herrlinger U; Gorlia T; Bähr O; Meyermann R; Bamberg M; Tatagiba M; von Deimling A; Weller M; Wick W
Int J Radiat Oncol Biol Phys; 2010 Jul; 77(3):670-6. PubMed ID: 19836157
[TBL] [Abstract][Full Text] [Related]
11. Temozolomide-induced liver damage. A case report.
Becker F; Hecht M; Schmidtner J; Semrau S; Fietkau R
Strahlenther Onkol; 2014 Apr; 190(4):408-10. PubMed ID: 24452817
[TBL] [Abstract][Full Text] [Related]
12. Postoperative radiotherapy and concomitant temozolomide for elderly patients with glioblastoma.
Gerstein J; Franz K; Steinbach JP; Seifert V; Fraunholz I; Weiss C; Rödel C
Radiother Oncol; 2010 Dec; 97(3):382-6. PubMed ID: 20850883
[TBL] [Abstract][Full Text] [Related]
13. Long-term use of temozolomide: could you use temozolomide safely for life in gliomas?
Khasraw M; Bell D; Wheeler H
J Clin Neurosci; 2009 Jun; 16(6):854-5. PubMed ID: 19303779
[TBL] [Abstract][Full Text] [Related]
14. Vanishing bile duct syndrome in the context of concurrent temozolomide for glioblastoma.
Mason M; Adeyi O; Fung S; Millar BA
BMJ Case Rep; 2014 Nov; 2014():. PubMed ID: 25432915
[TBL] [Abstract][Full Text] [Related]
15. Temozolomide-related acute lymphoblastic leukemia with translocation (4;11)(q21;q23) in a glioblastoma patient.
Chou KN; Lin YC; Liu MY; Chang PY
J Clin Neurosci; 2014 Apr; 21(4):701-4. PubMed ID: 24291476
[TBL] [Abstract][Full Text] [Related]
16. Accelerated hypofractionated intensity-modulated radiotherapy with concurrent and adjuvant temozolomide for patients with glioblastoma multiforme: a safety and efficacy analysis.
Panet-Raymond V; Souhami L; Roberge D; Kavan P; Shakibnia L; Muanza T; Lambert C; Leblanc R; Del Maestro R; Guiot MC; Shenouda G
Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):473-8. PubMed ID: 18554821
[TBL] [Abstract][Full Text] [Related]
17. [Side effects of temozolomide treatment in patient with glioblastoma multiforme--case study].
Łata S; Molczyk A
Przegl Lek; 2010; 67(5):445-6. PubMed ID: 20684359
[TBL] [Abstract][Full Text] [Related]
18. Severe sustained cholestatic hepatitis following temozolomide in a patient with glioblastoma multiforme: case study and review of data from the FDA adverse event reporting system.
Sarganas G; Orzechowski HD; Klimpel A; Thomae M; Kauffmann W; Herbst H; Bronder E; Garbe E
Neuro Oncol; 2012 May; 14(5):541-6. PubMed ID: 22394496
[TBL] [Abstract][Full Text] [Related]
19. Temozolomide-induced biliary ductopenia: a case report.
Balakrishnan A; Ledford R; Jaglal M
J Med Case Rep; 2016 Feb; 10():33. PubMed ID: 26846183
[TBL] [Abstract][Full Text] [Related]
20. Randomized phase II study of temozolomide and radiotherapy compared with radiotherapy alone in newly diagnosed glioblastoma multiforme.
Athanassiou H; Synodinou M; Maragoudakis E; Paraskevaidis M; Verigos C; Misailidou D; Antonadou D; Saris G; Beroukas K; Karageorgis P
J Clin Oncol; 2005 Apr; 23(10):2372-7. PubMed ID: 15800329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]